
Prenetics Global’s Chief Executive Officer, Danny Yeung, believes the company’s rapid expansion and Bitcoin treasury program are paving the way for profitability.
“Our ability to scale IM8 to nearly $100 million in ARR within a year, while maintaining a strong $90 million cash and Bitcoin position, underscores the strength of our model,” Yeung told Investing.com following the company’s earnings release on Friday.
“By combining high-growth consumer health with a disciplined Bitcoin treasury strategy, we’re positioning Prenetics to achieve profitability and deliver sustainable, long-term returns for shareholders.”
The comments come after Prenetics reported second-quarter revenue of $17.7 million, up a significant 594.9% year-on-year.
First-half revenue surged 452.1% to $32.3 million, driven by the IM8 brand, which generated $15.5 million in the period and reached $5.9 million in August alone.
Prenetics raised its full-year revenue guidance to a range of $85 million to $100 million.
Yeung highlighted execution as a key differentiator, telling Investing.com: “What sets Prenetics apart is the efficiency of our execution — IM8 has achieved industry-leading subscription rates, strong unit economics, and viral brand awareness, all while operating with disciplined capital allocation.”
He added that the firm’s Bitcoin treasury strategy reflects that same philosophy.
By steadily accumulating BTC from operating cash flows, we’re not only protecting against inflation but also creating asymmetric upside potential. Together, these initiatives highlight our conviction that health and wealth can be advanced in parallel, creating a company that is both resilient and growth-oriented.”
The company expects to achieve break-even by the first quarter of 2026 and deliver EBITDA-positive results thereafter.
Source :
https://www.investing.com/news/stock-market-news/prenetics-ceo-tells-investingcom-im8-growth-and-btc-strategy-to-drive-returns-4238493